Being Part of the New Health Frontier

In November last year, the House of Representatives Standing Committee on Health, Aged Care and Sport delivered its bipartisan report “The New Frontier: Delivering better health for all Australians” on the approval processes for new drugs and novel medical technologies in Australia.

Australian Health Journal spoke to some of the industry bodies who were part of the Inquiry, for their comments on the process, the report and hopes in the recommendations being implemented.

Professor John Zalcberg OAM Australian Clinical Trials Alliance (ACTA) Board Director & former ACTA Board Chair

Shanny Dyer, Chief Executive Officer, ARCS Australia

Leanne Wells, Chief Executive Officer, Consumers Health Forum of Australia

Liz de Somer, Chief Executive Officer Medicines Australia

Ian Burgess, Chief Executive Officer,
Medical Technology Association of Australia

Watch Season 5, Australian Health Journal Episode S5E1

Scroll to top